Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS) Insider Trading
Directors, officers and holders of more than 10% of ACRS report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 216 transactions on file: 0 with code P, 1 with code S and 49 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 1, 2026 | Kolbeck Roland Wilhelm | Chief Scientific Officer | M Exercise | 36,375 | Not measured | Not measured |
| Aug 1, 2026 | Kolbeck Roland Wilhelm | Chief Scientific Officer | M Exercise | 36,375 | Not measured | Not measured |
| Aug 1, 2026 | Kolbeck Roland Wilhelm | Chief Scientific Officer | F Tax Payment | 12,385 | $5.20 | $64,402 |
| Jun 5, 2026 | MILANO VINCENT | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | Humphries William D. | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | GOWEN MAXINE | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | Molineaux Christopher P. | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | Molineaux Christopher P. | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | SCHIFF ANDREW N | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | SCHIFF ANDREW N | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | Humphries William D. | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | Mehra Anand | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | Mehra Anand | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | GOWEN MAXINE | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 5, 2026 | MILANO VINCENT | Director | M Exercise | 11,580 | Not measured | Not measured |
| Jun 4, 2026 | MILANO VINCENT | Director | A Award | 42,350 | Not measured | Not measured |
| Jun 4, 2026 | Humphries William D. | Director | A Award | 10,987 | Not measured | Not measured |
| Jun 4, 2026 | GOWEN MAXINE | Director | A Award | 42,350 | Not measured | Not measured |
| Jun 4, 2026 | Mehra Anand | Director | A Award | 10,987 | Not measured | Not measured |
| Jun 4, 2026 | SCHIFF ANDREW N | Director | A Award | 10,987 | Not measured | Not measured |
| Jun 4, 2026 | Molineaux Christopher P. | Director | A Award | 42,350 | Not measured | Not measured |
| Jun 4, 2026 | Molineaux Christopher P. | Director | A Award | 10,987 | Not measured | Not measured |
| Jun 4, 2026 | SCHIFF ANDREW N | Director | A Award | 42,350 | Not measured | Not measured |
| Jun 4, 2026 | Mehra Anand | Director | A Award | 42,350 | Not measured | Not measured |
| Jun 4, 2026 | GOWEN MAXINE | Director | A Award | 10,987 | Not measured | Not measured |
| Jun 4, 2026 | Humphries William D. | Director | A Award | 42,350 | Not measured | Not measured |
| Jun 4, 2026 | MILANO VINCENT | Director | A Award | 10,987 | Not measured | Not measured |
| May 1, 2026 | Hall Jesse Wayne | Chief Medical Officer | M Exercise | 36,375 | Not measured | Not measured |
| May 1, 2026 | Hall Jesse Wayne | Chief Medical Officer | F Tax Payment | 9,330 | $4.41 | $41,145 |
| May 1, 2026 | Hall Jesse Wayne | Chief Medical Officer | M Exercise | 36,375 | Not measured | Not measured |
| Apr 23, 2026 | Leonard Braden Michael | 10% Owner | S Sale | 300,000 | $4.53 | $1,359,000 |
| Mar 1, 2026 | Balthaser Kevin | Chief Financial Officer | F Tax Payment | 677 | $2.87 | $1,943 |
| Mar 1, 2026 | Balthaser Kevin | Chief Financial Officer | M Exercise | 2,375 | Not measured | Not measured |
| Mar 1, 2026 | Balthaser Kevin | Chief Financial Officer | M Exercise | 2,375 | Not measured | Not measured |
| Feb 3, 2026 | Davis Hugh M. | President and COO | M Exercise | 18,675 | Not measured | Not measured |
| Feb 3, 2026 | Walker Neal | CEO | F Tax Payment | 18,611 | $3.47 | $64,580 |
| Feb 3, 2026 | Walker Neal | CEO | M Exercise | 63,475 | Not measured | Not measured |
| Feb 3, 2026 | Walker Neal | CEO | M Exercise | 63,475 | Not measured | Not measured |
| Feb 3, 2026 | Loerop James | Chief Business Officer | F Tax Payment | 5,937 | $3.47 | $20,601 |
| Feb 3, 2026 | Loerop James | Chief Business Officer | M Exercise | 20,875 | Not measured | Not measured |
| Feb 3, 2026 | Balthaser Kevin | Chief Financial Officer | F Tax Payment | 6,449 | $3.47 | $22,378 |
| Feb 3, 2026 | Balthaser Kevin | Chief Financial Officer | M Exercise | 22,025 | Not measured | Not measured |
| Feb 3, 2026 | Balthaser Kevin | Chief Financial Officer | M Exercise | 22,025 | Not measured | Not measured |
| Feb 3, 2026 | Davis Hugh M. | President and COO | M Exercise | 18,675 | Not measured | Not measured |
| Feb 3, 2026 | Loerop James | Chief Business Officer | M Exercise | 20,875 | Not measured | Not measured |
| Feb 2, 2026 | Balthaser Kevin | Chief Financial Officer | A Award | 346,800 | Not measured | Not measured |
| Feb 2, 2026 | Kolbeck Roland Wilhelm | Chief Scientific Officer | A Award | 95,700 | Not measured | Not measured |
| Feb 2, 2026 | Kolbeck Roland Wilhelm | Chief Scientific Officer | A Award | 334,900 | Not measured | Not measured |
| Feb 2, 2026 | Loerop James | Chief Business Officer | A Award | 97,700 | Not measured | Not measured |
| Feb 2, 2026 | Loerop James | Chief Business Officer | A Award | 341,900 | Not measured | Not measured |
The full Form 4 history is on the ACRS company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.